The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
U.K. experience of sunitinib malate in the treatment of metastatic renal cell carcinoma: Predictors of response from clinical practice.
Rebecca Allison Goranova
No relevant relationships to disclose
Bojidar Bojidarov Goranov
No relevant relationships to disclose
Ian David Pedley
No relevant relationships to disclose
Ashraf Azzabi
No relevant relationships to disclose
Alison Humphreys
No relevant relationships to disclose
Rhona McMenemin
No relevant relationships to disclose
John A. Frew
No relevant relationships to disclose